StrataGraft® Skin Tissue as an Alternative to Autografting Full-thickness Complex Skin Defects
Clinical trial NCT03005054 · TERMINATED
Trial details
- NCT number
- NCT03005054
- Sponsor
- Stratatech, a Mallinckrodt Company
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-04-24
- Primary completion
- 2019-03-26
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.